Halma (LON:HLMA – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Berenberg Bank in a research note issued on Friday, Digital Look reports. They currently have a GBX 4,200 target price on the stock. Berenberg Bank‘s price target points to a potential upside of 26.13% from the company’s current price.
Separately, Jefferies Financial Group reissued a “hold” rating and set a GBX 3,660 price objective on shares of Halma in a research report on Friday, September 25th. Four investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Halma currently has an average rating of “Moderate Buy” and a consensus target price of £6,856.03.
View Our Latest Report on HLMA
Halma Price Performance
LON:HLMA opened at GBX 3,330 on Friday. Halma has a 52 week low of GBX 3,198 and a 52 week high of GBX 4,902. The company has a quick ratio of 1.51, a current ratio of 2.14 and a debt-to-equity ratio of 42.13. The company has a market capitalization of £12.58 billion, a P/E ratio of 33.92, a P/E/G ratio of 2.93 and a beta of 0.98. The stock’s fifty day moving average is GBX 3,466.80 and its two-hundred day moving average is GBX 3,846.87.
Halma (LON:HLMA – Get Free Report) last announced its quarterly earnings results on Thursday, November 19th. The company reported GBX 66.24 EPS for the quarter. Halma had a return on equity of 17.92% and a net margin of 14.42%. The business had revenue of GBX 143.32 billion for the quarter. Equities analysts expect that Halma will post 90.56 EPS for the current year.
About Halma
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in: – Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety. – Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research. – Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.
See Also
- Five stocks we like better than Halma
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Halma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halma and related companies with MarketBeat.com's FREE daily email newsletter.
